SEC Company Response from Biofrontera AG (CIK 0001712641) — Feb 13, 2020
Biofrontera AG (CIK 0001712641)
Date: Feb. 13, 2020 · CIK: 0001712641 · Accession: 0001493152-20-002196
AI Filing Summary & Sentiment
File numbers found in text: 333-236021
Show Raw Text
CORRESP
1
filename1.htm
Biofrontera
AG
D-51377
Leverkusen Germany
February
13, 2020
VIA
EDGAR AND EMAIL
Paul
Fischer
Division
of Corporation Finance, Office of Life Sciences
United
States Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549-4561
Re:
Biofrontera
AG
Registration
Statement on Form F-3
File
No. 333-236021
Acceleration Request
Requested
Date:
February
18, 2020
Requested
Time:
9:30
a.m. Eastern Time (US)
Dear
Mr. Fischer:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned, on behalf of Biofrontera AG (the “Company”),
respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will
be declared effective at 9:30 a.m. Eastern Time on February 18, 2020, or at such later time as the Company, acting through its
counsel, McGuireWoods LLP, may request via a telephone call to the staff of the Division of Corporation Finance of the Securities
and Exchange Commission.
This
request supersedes our prior request for acceleration submitted on February 13, 2020.
Very
truly yours,
/s/
Thomas Schaffer
Thomas
Schaffer
Chief
Financial Officer
cc:
Stephen
E. Older, Esq.
Seth
Goldsamt, Esq.